Jean-Pierre Bizzari - Director, Halozyme Therapeutics, Inc
As of May 6, 2022
Jean-Pierre Bizzari Net Worth
- Net worth is estimated to be at least $4.25M
- Owns at least 52,544 units of Halozyme Therapeutics, Inc stock
- Sold an estimated value of $1.44M in the last 7 years at Halozyme Therapeutics, Inc
Jean-Pierre Bizzari Trading
- Largest sale of shares was 35,000 units , worth over $1.44M on August 25, 2021
- In total has made about 10 transactions over 7 years
- Usually trades in May, with the busiest year in 2021 and 2015
Jean-Pierre Bizzari
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Jean-Pierre Bizzari Mailing Address
- Mailing address is 235 Laurel Ln Haverfold PA 19041 PA
Halozyme Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Helen I. Torley | 2020 | $791,440 | - | $2,500,018 | $2,500,001 | $712,270 | $15,147 | $6,518,876 |
| Helen I. Torley | 2019 | $761,000 | - | $2,184,130 | $2,184,128 | $712,296 | $15,572 | $5,857,126 |
| Helen I. Torley | 2018 | $725,000 | - | $2,115,640 | $2,115,631 | $831,665 | $11,733 | $5,799,669 |
| Elaine D. Sun | 2020 | $395,833 | $150,000 | $1,500,269 | $1,000,008 | $180,352 | $133,399 | $3,359,861 |
| Laurie D. Stelzer | 2020 | $93,225 | - | $ | $ | $ | $77,996 | $171,221 |
| Laurie D. Stelzer | 2019 | $495,000 | $2,500 | $750,016 | $750,005 | $231,660 | $16,939 | $2,246,120 |
| Laurie D. Stelzer | 2018 | $470,000 | - | $575,018 | $575,009 | $323,489 | $9,409 | $1,952,925 |
| Masaru Matsuda | 2020 | $440,000 | $50,000 | $500,019 | $500,008 | $203,940 | $13,901 | $1,707,868 |
| Michael J. LaBarre | 2020 | $475,000 | - | $650,009 | $650,007 | $220,163 | $15,018 | $2,010,197 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm
Halozyme Therapeutics, Inc Insider Trading
- The most recent transaction was 50,000 units sold on November 8, 2021 by Helen Torley worth over $1.99M
- In the last 14 years, insiders at Halozyme Therapeutics, Inc sold an estimated value of $131.51M and bought an estimated value of $81.29M
- The most active traders are Helen Torley, President and CEO, Gregory Ian Frost, CEO, and Randal J Kirk
- Insider trading is most common in May and February, with the busiest year in 2007
HALOZYME THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||